GLP-1 RA Use May Up Risk for Gallbladder, Biliary Diseases

THURSDAY, March 31, 2022 (HealthDay News) -- Use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with increased risks for gallbladder or biliary diseases, with a higher risk for GLP-1 RA use in weight loss, according to a review published online March 28 in JAMA Internal Medicine.
Liyun He, from the Peking Union Medical College Hospital in China, and colleagues conducted a systematic review of randomized controlled trials (RCTs) comparing the use of GLP-1 RA drugs with placebo or with non-GLP-1 RA drugs in adults to examine the association with gallbladder and biliary diseases. Data from 76 RCTs with 103,371 patients were included in the meta-analysis.
The researchers found that randomization to GLP-1 RA treatment among all included trials was associated with increased risks for gallbladder or biliary diseases (pooled relative risk [RR], 1.37), specifically cholelithiasis, cholecystitis, and biliary disease (RRs, 1.27, 1.36, and 1.55, respectively). GLP-1 RA use was associated with an elevated risk for gallbladder or biliary diseases in trials for weight loss (13 trials; RR, 2.29) and for type 2 diabetes and other diseases (63 trials; RR, 1.27). For all included trials, the risks for gallbladder or biliary diseases were higher with higher doses of GLP-1 RA use versus lower doses and for longer versus shorter duration of use.
"Physicians should be concerned about the increased risk of gallbladder or biliary disease associated with GLP-1 RA use, especially at the higher doses recommended for weight loss," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Related Posts
Millions Could Lose Medicaid by April as Pandemic Rules Ease
WEDNESDAY, Jan. 4, 2023 (HealthDay News) -- Millions of Americans are about to...
Unos ‘compuestos permanentes’ podrían aumentar el riesgo de una complicación del embarazo
MARTES, 2 de noviembre de 2021 (HealthDay News) -- Los llamados "compuestos...
White House Announces Plan to Reduce Gun Suicides
TUESDAY, Nov. 2, 2021 (HealthDay News) -- The Biden administration unveiled a...
Western Wildfires Fueling Air Pollution During Summer Months
THURSDAY, April 21, 2022 (HealthDay News) -- Larger and more intense wildfires...
